Literature DB >> 11594930

Treatment of ballism and pseudobulbar affect with sertraline.

M S Okun1, A R Riestra, S E Nadeau.   

Abstract

BACKGROUND: The pathogenesis of ballism is uncertain and may involve more than one mechanism; treatment is not always efficacious.
OBJECTIVE: To provide evidence of a nondopaminergic mechanism and the potential for a prompt and nearly complete response to a serotonergic agent.
METHODS: Report of 2 separate trials of sertraline hydrochloride in a single patient.
RESULTS: Complete remission of symptoms within 48 hours of each drug trial.
CONCLUSION: Sertraline may offer an alternative with a better adverse effect profile than dopamine receptor blockers in the treatment of patients with ballism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594930     DOI: 10.1001/archneur.58.10.1682

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

Review 1.  Clinical trials of treatments for stroke.

Authors:  John Blass
Journal:  Curr Atheroscler Rep       Date:  2002-07       Impact factor: 5.113

Review 2.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

3.  Post stroke depression: treatments and complications in a young adult.

Authors:  Vincent F Capaldi; Gary H Wynn
Journal:  Psychiatr Q       Date:  2010-03

4.  Hemiballismus.

Authors:  Kathleen M Shannon
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.